Method of using niacin to control nocturnal cholesterol synthesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5268181
SERIAL NO

07905785

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a therapeutic method to treat hyperlipidemia by administering to a human patient a single daily dose of a prolonged release dosage form of niacin, so that nocturnal cholesterol synthesis is effectively suppressed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • KOS PHARMACEUTICALS, INC.;TCF NATIONAL BANK

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Evenstad, Kenneth L Wayzata, MN 17 331
O'Neill, Victoria A Wayzata, MN 27 440

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation